Independent, Science-Driven Assurance

DRMRC provides neutral inspection and oversight for biomaterials and clinical programs—verifying authenticity, ethics, and regulatory compliance for pharma, CROs, research centres, and agencies.

  • Biomaterial origin & quality inspection
  • Clinical trial monitoring & site oversight
  • GCP/GMP/GLP & global regulatory alignment
GCPGMPGLP WHOEMAMHRAFDA
DRMRC inspection and compliance imagery
Trusted inspection across sourcing, labs, and trials.

Our Third-Party Inspection Services

1 Biomaterial Origin & Quality Inspection
  • Supplier site inspections & handling audits
  • Origin & document verification (COA, GMP, ISO)
  • On-site sampling & independent lab testing
2 Clinical Trial Monitoring & Oversight
  • Protocol & ethics adherence; consent verification
  • Site audits, investigator compliance, data integrity
  • Interim analysis; AE/SAE tracking & reporting
3 Compliance Audits
  • GCP/GMP/GLP assessments
  • MHRA • EMA • FDA • WHO frameworks
4 Bioethics & Regulatory Review
  • Consent, patient rights, biospecimen governance
  • IRB/Ethics protocols & cross-border transport rules
5 Supplier & Partner Certification Validation
  • Licenses, certifications, sourcing practice checks
  • Facility audits & periodic documentation reviews
  • Supplier performance & consistency tracking
6 Data & Dossier Validation
  • Due diligence for reports and filings
  • Audit of lab findings, registration data, outcomes
Laboratory and facility audit representation
Independent lab & facility audits worldwide.

Deliverables You Can Expect

  • Inspection reports with compliance status & evidence
  • Risk assessments for materials, suppliers, or trial designs
  • Photographic/analytical documentation where applicable
  • Regulatory recommendations & CAPA guidance
  • Post-inspection consultation on next steps
Scroll to Top